Viz AAA is reportedly the first artificial intelligence (AI)-enabled algorithm to garner FDA 510(k) clearance for the detection of abdominal aortic aneurysm.
Over one million people in the United States have an abdominal aortic aneurysm (AAA).1 Aortic aneurysms claimed the lives of 9,904 people in the U.S. in 2019.2 Researchers have noted that mortality rates with AAAs could be underestimated as they may cause up to five percent of 200,000 sudden death cases annually in the U.S.3
However, Viz AAA (Viz.ai), an emerging artificial intelligence (AI)-powered algorithm, may facilitate earlier detection and treatment for people with AAAs. The Food and Drug Administration (FDA) has granted 510(k) clearance to Viz AAA, which provides automated AI assessments of computed tomography angiography (CTA) to detect suspected AAA, according to Viz.ai.4
Philip Batista, M.D., noted the majority of people with AAA are asymptomatic and lack awareness of the disease until they have a rupture. He called Viz AAA a significant advance for this high-risk population.
“This algorithm is a powerful new tool for healthcare professionals to more readily identify and capture individuals with AAA and, importantly, automatically refer those at imminent risk for rupture,” said Dr. Batista, an associate program director of Vascular and Endovascular Surgery Residency and assistant professor of surgery at the Cooper Medical School of Rowan University in New Jersey.
Viz.ai added that Viz AAA can be integrated into existing hospital workflows and will be available through the Viz AORTIC Module, an AI platform geared toward facilitating accelerated treatment of aortic pathology.
(Editor’s note: For related content, see “AI-Powered Algorithm May Enhance CT Assessment of Aortic Dissection” and “Could AI Improve Detection of Intracranial Aneurysms on CT Angiography?”)
References
1. Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010;52(3):539-48.
2. Centers for Disease Control and Prevention (CDC). Aortic aneurysm. Available at: https://www.cdc.gov/heartdisease/aortic_aneurysm.htm . Accessed March 22, 2023.
3. Schermerhorn M. A 66-year-old man with an abdominal aortic aneurysm: review of screening and treatment. JAMA. 2009;302(18):2015-22.
4. Viz.ai. Viz.ai is first to receive FDA 510(k) clearance for AI algorithm for abdominal aortic aneurysm. Available at: https://www.viz.ai/press-release/viz-ai-is-first-to-receive-fda-510-k-clearance-for-ai-algorithm-for-abdominal-aortic-aneurysm . Published March 21, 2023. Accessed March 22, 2023.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
New Literature Review Finds ChatGPT Effective in Radiology in 84 Percent of Studies
April 29th 2024While noting a variety of pitfalls with the chatbot ranging from hallucinations to improper citations, the review authors found the use of ChatGPT in radiology demonstrated “high performance” in 37 out of 44 studies.